SCHIZOAFFECTIVE DISORDERS

Clinical trials for SCHIZOAFFECTIVE DISORDERS explained in plain language.

Never miss a new study

Get alerted when new SCHIZOAFFECTIVE DISORDERS trials appear

Sign up with your email to follow new studies for SCHIZOAFFECTIVE DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New Long-Acting shot for schizophrenia shows promise in small study

Disease control Completed

This study tested a long-acting injectable form of risperidone (Risperdal Consta) in 31 people with schizophrenia or schizoaffective disorder who were already receiving home-care treatment. Participants switched from their usual antipsychotic medication to receive a shot every tw…

Matched conditions: SCHIZOAFFECTIVE DISORDERS

Phase: PHASE4 • Sponsor: Johnson & Johnson Taiwan Ltd • Aim: Disease control

Last updated Jun 27, 2026 13:01 UTC

SCHIZOAFFECTIVE DISORDERS

Get alerted when new SCHIZOAFFECTIVE DISORDERS trials appear

New Long-Acting shot for schizophrenia shows promise in small study